CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment

Tacrolimus is a commonly used immunosuppressant after kidney transplantation. It has a narrow therapeutic range and demonstrates wide interindividual variability in pharmacokinetics, leading to potential underimmunosuppression or toxicity. Genetic polymorphism in CYP3A5 enzyme expression contributes...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lucy, Prasad, G V Ramesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846312/
https://www.ncbi.nlm.nih.gov/pubmed/29563827
http://dx.doi.org/10.2147/PGPM.S107710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846312/
https://www.ncbi.nlm.nih.gov/pubmed/29563827
http://dx.doi.org/10.2147/PGPM.S107710

Ejemplares similares